A cutting-edge genetic test can rapidly detect and identify almost any kind of ... the mNGS test have received breakthrough ...
Patients who have two variants in the gene will likely be much sicker, much faster. Drug authorities in the UK and European Union have recommended pre-treatment DPYD testing since 2020.
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
Once millions used it to find out about their family histories - this week it was almost delisted. What went wrong?
Genetic testing could lower the risk of adverse drug reactions for thousands of patients with cancer
A new study led by Genomics England and Queen Mary University of London estimates that genetic testing could identify ...
Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...
23andMe currently lists two assets in early-stage testing ... mechanism drug targets ULBP6, which is secreted by tumor cells ...
Ibuprofen counters problems caused by mutations in the MAN1B1 gene, fruit fly tests show. Early results in three children are ”fairly positive.” ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Healthcare Asia on MSN1d
Saudi Arabia’s genetic testing market to grow 9.75% annually through 2029Increased awareness of genetic testing’s role in disease prevention is driving market growth. Saudi Arabia's genetic testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback